- Home
- TLSI vs ARQQ Comparison
TLSI vs ARQQ Comparison
Compare TLSI & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- ARQQ
- Stock Information
- Founded
- TLSI 2010
- ARQQ 2017
- Country
- TLSI United States
- ARQQ United Kingdom
- Employees
- TLSI N/A
- ARQQ N/A
- Industry
- TLSI Medical Specialities
- ARQQ Computer Software: Prepackaged Software
- Sector
- TLSI Health Care
- ARQQ Technology
- Exchange
- TLSI Nasdaq
- ARQQ Nasdaq
- Market Cap
- TLSI 160.4M
- ARQQ 173.1M
- IPO Year
- TLSI N/A
- ARQQ N/A
- Fundamental
- Price
- TLSI $5.74
- ARQQ $14.95
- Analyst Decision
- TLSI Strong Buy
- ARQQ Strong Buy
- Analyst Count
- TLSI 6
- ARQQ 1
- Target Price
- TLSI $11.75
- ARQQ $52.00
- AVG Volume (30 Days)
- TLSI 57.4K
- ARQQ 285.1K
- Earning Date
- TLSI 05-14-2025
- ARQQ 05-19-2025
- Dividend Yield
- TLSI N/A
- ARQQ N/A
- EPS Growth
- TLSI N/A
- ARQQ N/A
- EPS
- TLSI N/A
- ARQQ N/A
- Revenue
- TLSI $29,431,000.00
- ARQQ $293,000.00
- Revenue This Year
- TLSI $55.08
- ARQQ $1,818.77
- Revenue Next Year
- TLSI $50.75
- ARQQ N/A
- P/E Ratio
- TLSI N/A
- ARQQ N/A
- Revenue Growth
- TLSI 58.99
- ARQQ N/A
- 52 Week Low
- TLSI $3.50
- ARQQ $3.72
- 52 Week High
- TLSI $10.24
- ARQQ $52.79
- Technical
- Relative Strength Index (RSI)
- TLSI 59.91
- ARQQ 49.74
- Support Level
- TLSI $5.23
- ARQQ $13.80
- Resistance Level
- TLSI $5.66
- ARQQ $16.00
- Average True Range (ATR)
- TLSI 0.34
- ARQQ 1.48
- MACD
- TLSI 0.03
- ARQQ 0.18
- Stochastic Oscillator
- TLSI 92.94
- ARQQ 79.00
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product QuantumCloud. The firm operates in one segment that is, the provision of cybersecurity services via satellite and terrestrial platforms. The company operates and generates its revenue from UK.